Higher levels of B-cell mutation in the early germinal centres of an inefficient secondary antibody response to a variant influenza haemagglutinin

Immunology. 2019 May;157(1):86-91. doi: 10.1111/imm.13052. Epub 2019 Mar 11.

Abstract

Designing improved vaccines against mutable viruses such as dengue and influenza would be helped by a better understanding of how the B-cell memory compartment responds to variant antigens. Towards this we have recently shown, after secondary immunization of mice with a widely variant dengue virus envelope protein with only 63% amino acid identity, that IgM+ memory B cells with few mutations supported an efficient secondary germinal centre (GC) and serum response, superior to a primary response to the same protein. Here, further investigation of memory responses to variant proteins, using more closely related influenza virus haemagglutinins (HA) that were 82% identical, produced a variant-induced boost response in the GC dominated by highly mutated B cells that failed, not efficiently improving serum avidity even in the presence of extra adjuvant, and that was worse than a primary response. This supports a hypothesis that over a certain level of antigenic differences, cross-reactive memory B-cell populations have reduced competency for affinity maturation. Combined with our previous observations, these findings also provide new parameters of success and failure in antibody memory responses.

Keywords: B-cell memory; affinity maturation; antibodies; cross-reactive; influenza virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibody Affinity
  • B-Lymphocytes / physiology*
  • Cross Reactions
  • Female
  • Germinal Center / immunology*
  • Hemagglutinins, Viral / genetics
  • Hemagglutinins, Viral / metabolism
  • Humans
  • Immunity, Humoral
  • Immunization, Secondary
  • Immunologic Memory
  • Influenza Vaccines / immunology*
  • Influenza, Human / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Mutation / genetics
  • Polymorphism, Genetic
  • Receptors, Antigen, B-Cell / genetics*

Substances

  • Hemagglutinins, Viral
  • Influenza Vaccines
  • Receptors, Antigen, B-Cell